Роль и влияние недостатка глутатиона в постковидном периоде

Нуриллаева Наргиза Мухтархановна, Омаров Хасан Бахтович, Хасанова Наргиза Абдумухтаровна

dc.contributor.author	Нуриллаева Наргиза Мухтархановна, Омаров Хасан Бахтович, Хасанова Наргиза Абдумухтаровна
dc.date.accessioned	2022-10-11T08:13:21Z
dc.date.available	2022-10-11T08:13:21Z
dc.date.issued	2022
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/3010
dc.description.abstract	The clinical condition of 58 patients with COVID - 19 who arrived for inpatient treatment at the cardiology department of the TMA multidisciplinary clinic, 20-30 days after the disappearance of symptoms of coronavirus infection, was analyzed. Several pieces of evidence presented in our biochemical analysis suggest that low GSH levels may be one of the main causes of the excessive inflammatory response associated with severe COVID-19 symptoms and indicate that an increase in GSH in the body may reduce the number of symptomatic patients. Future clinical studies of GSH levels in patients with COVID-19 may be a starting point to explore this possibility	en_US
dc.language.iso	en	en_US
dc.publisher	Узбекистан	en_US
dc.subject	глутатион, постковидный период	en_US
dc.title	Роль и влияние недостатка глутатиона в постковидном периоде	en_US
dc.type	Article	en_US